Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 8, 2001, Pages 2390-2392

  Martinez Martinez L ^a   Joyanes, P ^a   Suarez A I ^a   Perea, E J ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; DOXYCYCLINE; GEMIFLOXACIN; GENTAMICIN; VANCOMYCIN;

ACTINOMYCETALES; ARTICLE; BACTERIUM ISOLATION; DRUG ACTIVITY; DRUG INHIBITION; IN VITRO STUDY; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CORYNEBACTERIUM; FLUOROQUINOLONES; HUMANS; LISTERIA MONOCYTOGENES; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES;

EID: 0034923007     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.8.2390-2392.2001     Document Type: Article

References (21)

1. Corynebacterium amycolatum sp. nov., a new mycolic acid-less Corynebacterium species from human skin
2. Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum
3. Antimicrobial susceptibility patterns of some recently established coryneform bacteria
4. Clinical significance of coryneform bacteria
5. In vitro activity of 79 antimicrobial agents against Corynebacterium group D2
6. Clinical significance of newly recognized coryneform bacteria
7. Antimicrobial susceptibility pattern of Corynebacterium striatum
8. Comparison of E-test with broth microdilution and disk diffusion for susceptibility testing of coryneform bacteria
9. In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against coryneform bacteria
10. In vitro activity of levofloxacin, ofloxacin and D-ofloxacin against coryneform bacteria of clinical interest
11. Comparative in vitro activities of new quinolones against coryneform bacteria
12. Phenotypic characteristics of 31 strains of Corynebacterium striatum isolated from clinical samples
13. In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics
14. Species identities and antimicrobial susceptibilities of corynebacteria isolated from various clinical sources
15. Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid
16. Increasing incidence of Corynebacterium group D2 strains resistant to norfloxacin and ciprofloxacin
17. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents
18. Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods
19. The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone